
Cochlear™
Baha® 5 SuperPower Sound Processor
ZONE EN-US
English
3
EN-US
User manual part A
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional
will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all
countries. Please contact your local Cochlear representative for product information. In Australia, Baha bone conduction implant systems
are intended for the treatment of moderate to profound hearing loss. For the Cochlear Baha System in Australia: This product is not
available for purchase by the general public. For information on funding and reimbursement please contact your healthcare professional.
Cochlear, Baha, 科利耳, コクレア, 코클리어, Hear now. And always, SmartSound, the elliptical logo, and marks bearing an ® or ™ symbol,
are either trademarks or registered trademarks of the Cochlear group of companies (unless otherwise noted).
Apple, the Apple logo, iPhone, iPad and iPod are trademarks of Apple Inc., registered in the U.S. and other countries.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Cochlear
Limited is under license.
© Cochlear Bone Anchored Solutions AB 2022. All rights reserved. 2022-12
P2046687 D2046713-V1
SE Cochlear Bone Anchored Solutions AB, Konstruktionsvägen 14, 435 33 Mölnlycke, Sweden. Tel:+46 31 792 44 00
AU Cochlear Ltd, (ABN 96 002 618 073), 1 University Avenue,
Macquarie University, NSW 2109 Australia. Tel:+61 2 9428 6555
US Cochlear Americas, 10350 Park Meadows Drive, Lone Tree,
CO 80124, USA. Tel:+1 303 790 9010
CH Cochlear AG, Peter Merian-Weg 4, 4052 Basel,
Switzerland. Tel:+41 61 205 8204
PA Cochlear Latinoamerica, S. A.,
International Business Park Building 3835, Office 403 Panama Pacifico,
Panama. Tel:+507 830 6220
GB UK Responsible Person: Cochlear Europe Ltd,
6 Dashwood Lang Road, Bourne Business Park, Addlestone, Surrey,
KT15 2HJ, United Kingdom. Tel:+44 1932 26 3400
DE Cochlear Deutschland GmbH & Co. KG, Mailänder Straße 4a,
30539 Hannover, Germany. Tel:+49 511 542 770
BE Cochlear Benelux NV, Schaliënhoevedreef 20 I,
2800 Mechelen, Belgium. Tel:+32 15 79 55 11
FR Cochlear France S.A.S., 135 route de Saint Simon,
31035 Toulouse, France. Tel:+33 5 34 63 85 85 (international),
Tel: 0805 200 016 (national)
IT Cochlear Italia s.r.l, Via Trattati Comunitari Europei
1957 2007 n.17, 40127 Bologna (BO) Italy. Tel:+39 051 601 53 11
TR Cochlear Tıbbi Cihazlar ve Sağlık
Hizmetleri Ltd. Sti., Küçükbakkalköy Mah, Defne Sok, Büyükhanlı
Plaza No:3 Kat:3 Daire: 9-10-11-12, 34750, Ataşehir, İstanbul,
Türkiye. Tel:+90 216 538 59 00
SE Cochlear Nordic AB, Konstruktionsvägen 14, 435 33 Mölnlycke,
Sweden. Tel:+46 31 335 14 61
CA Cochlear Canada Inc, 2500-120 Adelaide Street West, Toronto,
ON M5H 1T1, Canada. Tel:+1 800 483 3123
JP Nihon Cochlear Co Ltd, Ochanomizu-Motomachi
Bldg 2-3-7 Hongo, Bunkyo-Ku, Tokyo 113-0033,
Japan. Tel:+81 3 3817 0241
SG Cochlear Limited (Singapore Branch),
238A Thomson Road #25-06, Novena Square Office Tower A,
Singapore 307684, Singapore. Phone: +65 65533814
CN Cochlear Medical Device (Beijing) Co Ltd, Unit 2608-2617,
26th Floor, No.9 Building, No.91 Jianguo Road, Chaoyang District,
Beijing 100022, P.R. China. Tel:+86 10 5909 7800
HK Cochlear (HK) Ltd, Room 1404-1406, 14/F, Leighton Centre,
77 Leighton Road, Causeway Bay, Hong Kong. Tel:+852 2530 5773
IN Cochlear Medical Device Company India PVT Ltd,
Platina Bldg, Ground Floor, Plot No. C 59, G Block, BKC, Bandra East,
Mumbai 400051 India. Tel:+91 22 6112 1111
CO Cochlear Colombia,
Avenida Carrera 9 #115-06 Of. 1201 Edificio Tierra Firme,
Bogota D.C., Colombia. Tel:+57 315 339 7169 / +57 315 332 5483
MX Cochlear México S.A. de C.V, Av. Tamaulipas 150 Torre A piso 9,
Col. Hipódromo Condesa, 06170 Cuauhtémoc, Ciudad de México,
México. Tel:+52 0155 5256 2199
www.cochlear.com
Sound processor type designations for
models included in this User Manual are:
FCC ID: QZ3BAHA5SUP, IC: 8039C-BAHA5SUP, IC model:
Baha®5 SUP.
Statement:
This device complies with Part 15 of the FCC Rules.
Operation is subject to the following two conditions:
(1) this device may not cause harmful interference, and
(2) this device must accept any interference received,
including interference that may cause undesired operation.
Note: This equipment has been tested and found to
comply with the limits for a Class B digital device, pursuant
to part 15 of the FCC Rules. These limits are designed to
provide reasonable protection against harmful interference
in a residential installation. This equipment generates, uses
and can radiate radio frequency energy and, if not installed
and used in accordance with the instructions, may cause
harmful interference to radio communications. However,
there is no guarantee that interference will not occur in
a particular installation. If this equipment does cause
harmful interference to radio or television reception, which
can be determined by turning the equipment off and on,
the user is encouraged to try to correct the interference by
one or more of the following measures:
• Reorient or relocate the receiving antenna.
• Increase the separation between the equipment and
receiver.
• Connect the equipment into an outlet on a circuit
different from the one in which the receiver is connected.
• Consult the dealer or an experienced radio/TV technician
for help.
• Changes or modifications can void the user’s authority
to operate the equipment.
Intended use
The Cochlear™Baha®5 SuperPower uses bone conduction
to transmit sounds to the cochlea (inner ear). It is
indicated for people with conductive hearing loss, mixed
hearing loss and single sided sensorineural deafness (SSD).
Furthermore it is indicated for bilateral and paediatric
recipients. Fitting range up to 65 dB SNHL. It works by
combining a sound processor and a small titanium implant
that is placed in the skull behind the ear. The skull bone
integrates with the titanium implant through a process
called osseointegration. This allows sound to be conducted
via the skull bone directly to the cochlea, which improves
hearing performance. The sound processor can be used
together with the Baha Softband.
The fitting is to be done either at a hospital, by an
audiologist, or in some countries, by a hearing care
professional.
List of countries:
Not all products are available in all markets. Product
availability is subject to regulatory approval in the
respective markets.
The products are in compliance with the following
regulatory requirements:
• In EU: the device conforms to the Essential Requirements
according to Annex I of Council Directive 93/42/EEC for
medical devices (MDD) and essential requirements and
other relevant provisions of Directive 2014/53/EU (RED).
The declaration of conformity may be consulted at www.
cochlear.com.
• Other identified applicable international regulatory
requirements in countries outside the EU and US. Please
refer to local country requirements for these areas.
• In Canada the sound processor is certified under the
following certification number: IC: 8039C-BAHA5SUP
and model no.: IC model: Baha®5 SUP.
• This device complies with Industry Canada licence-
exempt RSS standard(s).
• This Class B digital apparatus complies with Canadian
ICES-003. Cet appareil numérique de la classe B est
conforme à la norme NMB-003 du Canada.
• Operation is subject to the following two conditions:
(1) this device may not cause interference, and (2)
this device must accept any interference, including
interference that may cause undesired operation
of the device. L’exploitation est autorisée aux deux
conditions suivantes : (1) l’appareil ne doit pas produire
de brouillage, et (2) l’utilisateur de l’appareil doit
accepter tout brouillage radioélectrique subi, même
si le brouillage est susceptible d’en compromettre le
fonctionnement.
Equipment includes RF transmitter
Note: The sound processor is suited for use
in a home healthcare environment. The home healthcare
environment includes locations such as homes, schools,
churches, restaurants, hotels, cars, and airplanes, where
equipment and systems are less likely to be administered
by healthcare professionals.